Disclosure: Some links on this page are affiliate links. If you purchase through these links, we may earn a commission at no extra cost to you.

Find My GLP-1 Path

Affiliate disclosure: The RX Index earns a commission when you sign up with some of the providers mentioned on this page. It does not affect what you pay, and it never determines our rankings or which providers we cover. Read the full disclosure.

FEHB GUIDEFEP BLUE5 PATHS COMPAREDVERIFIED MAY 2026

GLP-1 Providers That Accept FEP Blue in 2026: 5 Paths, Prior Approval, Formulary Exceptions, and Real Costs

Published: · Last reviewed:

By The RX Index Editorial Team · FEP formulary verified · Provider pages checked · PA criteria sourced from CVS Caremark FEP

The RX Index is an independent comparison resource for GLP-1 telehealth providers. This is not medical advice and is not affiliated with Blue Cross Blue Shield, the BCBSA, OPM, or any FEHB carrier. Talk to your clinician and your FEP plan administrator about your specific situation.

FEP Blue GLP-1 prior authorization — federal employee choosing the right path for Wegovy or Zepbound coverage

The bottom line

FEP Blue does cover FDA-approved GLP-1 weight-loss medications in 2026 — but not all of them the same way, and not all on every plan. Wegovy (semaglutide injection) is a covered drug on Standard and Basic, needing standard prior approval. Zepbound (tirzepatide) is exception-driven on every FEP plan — excluded on Standard, Managed Not Covered on Basic, and off the Focus formulary. There is no single "FEP Blue covers GLP-1s" answer. There are five real paths, and which one applies to you depends on your plan, your drug, and your documentation.

Want Ro to check your FEP Blue coverage and submit the PA?

Ro has an explicit FEHB carve-out and handles prior approval and formulary exception paperwork for you.

Check Ro FEHB Coverage → (sponsored affiliate link, opens in a new tab)

Quick-glance: which path fits your situation?

FEP Blue GLP-1 coverage paths by situation
Your situationThe likely FEP pathRecommended starting point
FEP Standard or Basic, want WegovyStandard prior approval (PA) — not a formulary exceptionRo insurance concierge or FEP Teladoc
FEP Standard or Basic, want ZepboundFormulary exception — heavier documentation than PAIn-network FEP clinician or Ro concierge
FEP Blue Focus (any drug)Non-formulary exception — closed formulary applies to allIn-network FEP clinician; verify all household meds first
Postal worker (PSHB)Same FEP rules — same formulary, same PA criteria, same formsConfirm PSHB support with each provider's intake team
FEP retiree on MPDPMPDP process — different formulary, different phone lineCall 1-855-344-0930 or log into MyBlue for MPDP drug cost
FEP denied, considering cash-payFDA-approved self-pay — Ro, Sesame, LillyDirect, NovoCareExhaust FEP appeal first; then compare cash-pay options

What "accepts FEP Blue" actually means — and why most providers don't

When a GLP-1 telehealth provider says it "accepts" or "supports" FEP Blue, it usually means one of three things — and they are not the same:

  1. The provider accepts your insurance card to bill the membership or visit fee directly to FEP. Very few GLP-1 telehealth providers do this. Most charge a cash-pay membership fee regardless of your insurance.
  2. The provider's clinical team submits your prior approval or formulary exception paperwork to FEP/CVS Caremark on your behalf. This is what Ro's insurance concierge does. The membership fee is still cash-pay; the medication runs through your FEP pharmacy benefit after approval.
  3. The provider prescribes the medication and you use your FEP pharmacy benefit independently. This includes your in-network FEP primary care clinician or obesity-medicine specialist. No concierge service — you coordinate the PA yourself or through your clinician's office.

The correct question is not "does this provider accept FEP Blue?" The correct question is: will this provider submit my prior approval or formulary exception paperwork to FEP, and what happens after FEP decides?

One more thing that many providers skip: FEP Blue Basic and FEP Blue Focus members cannot use their pharmacy benefit at non-preferred retail pharmacies. Out-of-network means full cash price. Before any GLP-1 path works, your prescription must go to a preferred retail pharmacy, the FEP Mail Service Program, or the FEP Specialty Pharmacy Program.

FEP Blue 2026 GLP-1 coverage matrix

The following table reflects FEP's 2026 Abbreviated Formulary and FEP's pharmacy FAQ. There is a known discrepancy between those two sources on Wegovy's tier: the Abbreviated Formulary shows Tier 3; the FAQ says Tier 2 is correct and the formulary data is being updated. For your actual cost-share, use the Personalized Drug Cost Tool in MyBlue — not this table.

FEP Blue 2026 GLP-1 formulary status by plan and drug
DrugStandardBasicFocusRoute needed
Wegovy pen (semaglutide)Tier 3 anti-obesity (formulary says) / Tier 2 (FAQ says) — data being correctedSame as StandardNC in formulary / Tier 2 after non-formulary exception (FAQ)Standard PA (Standard/Basic); non-formulary exception (Focus)
Saxenda (liraglutide)Tier 3 anti-obesityTier 3 anti-obesityNCStandard PA (Standard/Basic); non-formulary exception (Focus)
Zepbound pen (tirzepatide)Excluded / Tier 3 non-preferred after formulary exception (FAQ)Managed Not Covered / Tier 3 after formulary exception (FAQ)Not on formulary / Tier 2 after non-formulary exception (FAQ)Formulary exception (Standard/Basic); non-formulary exception (Focus)
Foundayo (orforglipron)Not in 2026 formulary (FDA-approved April 1, 2026)Not in 2026 formularyNot in 2026 formularyVerify in MyBlue — may have been added mid-year
Ozempic / Mounjaro (type 2 diabetes)Covered for T2D with PA; off-label weight-loss coverage harder to obtainSame as StandardVerify in MyBluePA for T2D; off-label weight-loss coverage not guaranteed

Source: FEP 2026 Abbreviated Formulary; FEP pharmacy FAQ (fepblue.org/faqs/faq-pharmacy). Verified May 12, 2026. Your actual tier and cost-share must be confirmed in MyBlue's Personalized Drug Cost Tool.

5 provider paths compared

Federal employees navigating GLP-1 coverage have five realistic routes. The table below captures what each path actually does — and doesn't do — for your FEP Blue benefit.

Five GLP-1 provider paths for FEP Blue members compared by function, coverage support, and cost structure
Provider pathMembership/visit feePA/exception supportMedication channelFEP pharmacy benefitAffiliate?
Ro (FEHB carve-out)Cash-pay membershipYes — Ro's concierge submits PA or formulary exception to FEP/CVS CaremarkFEP preferred pharmacy after approvalYes — at your tier cost-share after PA/exceptionYes
FEP Teladoc Weight ManagementCovered under FEP benefitTeladoc clinicians can prescribe and submit PA within FEP's system; Teladoc is FEP's named comprehensive weight-management program exampleFEP preferred pharmacyYes — medication through FEP pharmacy benefitNo
Sesame CareCash-pay per visitClinician can prescribe; PA submission capability varies by Sesame clinician — verify directlyFEP preferred pharmacy or Sesame branded pricingPotentially — verify your clinician's PA workflow with Sesame intakeYes
In-network FEP clinicianFEP medical benefit (subject to deductible/copay)Yes — your clinician's office submits ePA or calls 1-877-727-3784FEP preferred pharmacyYes — medication through FEP pharmacy benefitNo
Cash-pay after denialCash-pay onlyNot applicable — FEP benefit not usedLillyDirect, NovoCare, Ro self-pay, or SesameNo — full cash priceRo and Sesame are affiliate links

Path 1: Ro — the FEHB insurance concierge route

What Ro actually does for FEP Blue members: Ro Body membership is cash-pay. You pay Ro's membership fee out-of-pocket. What Ro adds for federal employees is an explicit FEHB carve-out: Ro's insurance concierge team checks your FEP Blue coverage, and — if a GLP-1 is clinically appropriate — submits the prior approval or formulary exception paperwork to FEP/CVS Caremark on your behalf.

Ro's current FEHB-eligible GLP-1 list (from ro.co/weight-loss/insurance/, verified May 2026): Wegovy pen, Zepbound pen, and Ozempic. Ro does not list Wegovy pill, Foundayo, or Saxenda as insurance-pathway options.

What happens after FEP approves: Your medication is filled at your in-network FEP preferred pharmacy at your assigned tier cost-share. Ro's membership fee is separate from your medication cost.

Why Ro is the starting point for most FEP Blue members seeking Wegovy or Zepbound: Most federal employees' primary care clinicians are comfortable submitting routine prior authorizations — but formulary exception paperwork for Zepbound is a heavier documentation burden that involves multiple criteria. Ro's concierge is built for exactly this workflow. If FEP denies the request, Ro also offers FDA-approved cash-pay at manufacturer-direct pricing.

The FEHB carve-out language — verified on Ro's site: Ro explicitly notes that FEHB members are not eligible for Ro's state-specific insurance billing (which covers commercial plans) and instead routes FEHB members through Ro's separate insurance concierge pathway. This is not a workaround — it is Ro's stated policy for federal employees.

One important caveat: Ro is not a benefit broker and cannot guarantee any specific coverage outcome. Whether your FEP prior approval or exception is granted depends on FEP/CVS Caremark's clinical review, not on Ro's team.

Check coverage eligibility with Ro's FEHB concierge

Ro handles PA and formulary exception submission for FEP Blue members. Membership is cash-pay; medication uses your FEP pharmacy benefit.

Check Ro FEHB Coverage → (sponsored affiliate link, opens in a new tab)

Path 2: FEP Teladoc Weight Management — FEP's named example program

FEP's prior approval criteria explicitly name participation in a "comprehensive weight management program" as a requirement for Wegovy and Zepbound. FEP's own documentation lists Teladoc Weight Management as an example of a qualifying program.

What FEP Teladoc Weight Management does: FEP members enrolled in Standard, Basic, or Focus can access Teladoc Health's weight management program as a covered benefit. Teladoc clinicians can evaluate GLP-1 appropriateness, prescribe if clinically warranted, and submit the PA to FEP through the FEP-specific prior authorization process. The program also generates the weight-management-program documentation that FEP's PA criteria require.

Why this path matters for your documentation file: If you plan to pursue a Zepbound formulary exception — where the documentation burden is higher — enrolling in FEP Teladoc Weight Management before submitting the exception request gives your clinician documented evidence of the "comprehensive weight management program participation" criterion. Waiting until after denial to start the program is a common mistake.

How to access: Log into MyBlue at fepblue.org, navigate to the weight management section, and enroll in FEP Teladoc Weight Management. You can also reach FEP Customer Care at 1-800-411-2583 for enrollment guidance.

FEP Teladoc is not an affiliate relationship. We include it because it is FEP's own named program and because failing to use a qualifying weight management program is the second-most-common reason for FEP GLP-1 PA denial (after incomplete BMI documentation).

Path 3: Sesame Care — cash-pay visits with potential PA support

Sesame Care is a cash-pay telehealth marketplace where you pay per visit rather than a monthly membership. A licensed Sesame clinician can prescribe GLP-1s and, depending on the specific clinician, submit prior authorization paperwork to FEP/CVS Caremark.

What Sesame can do for FEP Blue members: Sesame clinicians can prescribe GLP-1s and may be able to submit PA requests. Unlike Ro's dedicated FEHB insurance concierge, Sesame's PA support is clinician-dependent — verify with Sesame's intake team whether your specific clinician handles FEP prior authorization submissions.

The federal-program exclusion on Sesame's promotional offers: Sesame has promotional pricing on some Wegovy and Ozempic programs. Per Sesame's own terms, if you are enrolled in FEHB or MPDP with prescription drug coverage, you may not be eligible for those specific promotional offers. Verify directly on Sesame's site before assuming any promotional rate applies to you.

What Sesame does provide: Sesame's branded medication menu, per-visit pricing, and the ability to provide itemized receipts for HSA/FSA submission. Sesame does not lock you into a monthly membership.

Sesame Care — per-visit GLP-1 prescriptions

Pay per visit, no monthly membership. Confirm PA support with Sesame intake before paying. Federal promo exclusion may apply.

See Sesame Pricing → (sponsored affiliate link, opens in a new tab)

Path 4: Your in-network FEP clinician — the no-concierge route

If you have an established relationship with an in-network FEP primary care physician or an obesity-medicine specialist, you may not need a telehealth service at all. Your clinician can prescribe a GLP-1, submit the prior authorization or formulary exception to CVS Caremark's FEP process directly, and send the prescription to your preferred FEP pharmacy.

The reality check: Many primary care clinicians submit routine prior authorizations routinely. However, the Zepbound formulary exception has a more complex documentation requirement — including evidence of two oral weight-management medication trials and evidence of a Wegovy or Saxenda trial (or a clinical reason those are medically inappropriate). Not every clinician's office is set up to compile this paperwork efficiently.

How to submit: Electronic prior authorization (ePA) is the fastest route. Your clinician can also call FEP/CVS Caremark at 1-877-727-3784 (this is a phone number, not a fax) or complete the FEP prior approval request form or formulary exception form from fepblue.org/forms.

One pharmacy requirement to flag: FEP Blue Basic and FEP Blue Focus members cannot use their pharmacy benefit at non-preferred retail pharmacies. If your clinician sends the prescription to an out-of-network pharmacy, you pay the full cash price even if the PA was approved. FEP has more than 55,000 preferred retail pharmacies plus the FEP Mail Service Program and FEP Specialty Pharmacy Program.

Path 5: FEP-covered telehealth for existing FEP members without a primary care clinician

FEP Standard, Basic, and Focus members who do not have an established primary care clinician can access FEP's broader telehealth benefit to get a GLP-1 evaluation and PA submission from a licensed clinician within FEP's coverage. This is distinct from FEP Teladoc Weight Management (which is specifically the weight management program) — FEP's general telehealth benefit covers evaluation and prescription services as well.

Check your specific plan's telehealth benefit in MyBlue for participating telehealth providers and any cost-share.

FEP Blue prior approval vs. formulary exception — what's the difference?

FEP Blue has two separate approval routes for GLP-1 medications. Prior approval is for a covered drug that needs clinical review before FEP pays. Formulary exception is for an excluded or Managed Not Covered drug — your clinician asks FEP to cover it anyway because of medical necessity. Wegovy on Standard and Basic generally needs prior approval. Zepbound on Standard and Basic generally needs a formulary exception. On FEP Blue Focus, both usually need a non-formulary exception. Once approved, your medication fills at your in-network FEP pharmacy at the assigned tier cost-share.

This is the distinction that trips up almost every federal employee — and even some clinicians' offices. Get it right and your paperwork lands on the right desk the first time. Get it wrong and you wait two extra weeks for a do-over.

The decision tree

Is the medication a "covered drug" that just needs PA?

→ Use FEP's standard prior approval process. Submit by electronic prior authorization (ePA), by calling FEP/CVS Caremark at 1-877-727-3784 (phone, not fax), or by completing the FEP prior approval request form.

Is the medication excluded or Managed Not Covered on your plan?

→ Use FEP's formulary exception process. Download the right form:

  • Traditional FEHB and PSHB (postal workers): FEP Traditional Formulary Exception Form
  • MPDP (retirees with Medicare combo plan): FEP MPDP Formulary Exception Form

Both forms are downloadable from fepblue.org/forms.

Is the medication not on your plan's formulary at all (FEP Blue Focus)?

→ Use FEP's non-formulary exception process for Focus members. Your clinician submits documentation that the non-formulary medication is medically necessary.

Step-by-step: Wegovy or Zepbound prior approval

Step 1: Confirm you meet the FEP criteria.

For initial approval, FEP requires:

  • Age 18 or older: BMI of 30 or higher, or BMI of 27 or higher with at least one of: type 2 diabetes, high blood pressure (hypertension), high cholesterol or triglycerides (dyslipidemia), or established cardiovascular disease (heart attack history, stroke history, coronary artery disease, peripheral artery disease, or prior coronary intervention)
  • Age 12–17 (Wegovy only): BMI at or above the 95th percentile for age
  • Participation in a comprehensive weight management program — Teladoc is FEP's named example; other structured programs count
  • No concurrent PA-required weight-loss medication — discontinue any conflicting medication before resubmitting

Step 2: Identify whether you need PA, formulary exception, or non-formulary exception. Use the decision tree above. Your plan plus your drug determines which form.

Step 3: Your clinician submits the request by electronic prior authorization (ePA), by calling 1-877-727-3784, or by completing the appropriate form. If you go through Ro's insurance concierge, Ro's team handles this for you.

Step 4: Wait for the decision. CVS Caremark reviews against the FEP criteria. Initial approval is for 6 months.

Step 5: Fill at your in-network FEP pharmacy. FEP Blue Basic and FEP Blue Focus members cannot use non-preferred retail pharmacies. Out-of-network means full cash price.

Renewal at month 6 — don't skip this

For renewal, FEP requires:

  • Adults 18+: Documented at least 5% weight loss from baseline, or maintenance of an initial 5% loss
  • Continued weight-management-program participation
  • Still no dual-PA weight-loss medication therapy

Renewals are approved in 12-month blocks after the first 6-month initial.

Practical tip: Get your starting weight recorded by a clinician on day one of therapy. If you lose less than 5% by month 6 and have no baseline documentation, your renewal is at risk.

What if you want Zepbound specifically?

Zepbound on FEP Blue is exception-driven on every plan. To get coverage, your clinician needs to document FEP's full Zepbound criteria: BMI/comorbidity, participation in a comprehensive weight management program, no dual GLP-1 or PA weight-loss therapy, inadequate response, intolerance, or contraindication to at least two oral weight-management medications, and trial of FEP's preferred product(s) unless there's a valid medical exception. Plan on a higher documentation burden than Wegovy.

FEP's Zepbound criteria (CVS Caremark FEP Criteria document, December 2025) are tougher than Wegovy's. Going in with a partial file is the #1 reason Zepbound exceptions get denied on FEP Blue.

The Zepbound exception burden checklist

Zepbound formulary exception checklist for FEP Blue members
Required by FEPWhy it mattersWhat document proves it
BMI 30+, or BMI 27+ with a qualifying conditionSets clinical eligibility thresholdRecent clinical visit note with weight, height, BMI; ICD-10 code for any comorbidity
Participation in a comprehensive weight management programFEP requires structured behavioral and lifestyle support alongside medicationFEP Teladoc Weight Management enrollment, Noom/WW participation log, or obesity-medicine clinic program records
No dual GLP-1 therapyPrevents concurrent semaglutide + tirzepatide overlapMedication reconciliation note from clinician
No concurrent PA-required weight-loss medicationPrevents stacked weight-loss prescriptionsPrescription history check + discontinuation note if needed
Inadequate response, intolerance, or contraindication to at least two oral weight-management medicationsFEP requires evidence that simpler options didn't work firstTrial history for phentermine, Qsymia, Contrave, or other oral anti-obesity meds, with documented outcome or side effects
Trial of FEP's preferred product(s) unless valid medical exceptionWegovy or Saxenda is FEP's preferred formulary pathway; Zepbound is the step-upDocumentation of Wegovy or Saxenda trial — or a clinical reason it is medically inappropriate (e.g., contraindication, prior intolerance, OSA indication)

One clean note on FDA approvals: Zepbound has separate FDA approvals for chronic weight management and for obstructive sleep apnea in adults with obesity. If you have a documented sleep apnea diagnosis along with obesity, the OSA indication is a legitimate Zepbound pathway that some PA reviewers handle differently than the weight-loss-only request.

Plain-English rule: Don't go in saying "I want Zepbound." Go in with documented BMI and comorbidity, your weight-management-program enrollment, your trial history with at least two oral weight-loss medications, your Wegovy or Saxenda trial documentation (or the clinical reason you can't use those), and your clinician's written rationale for Zepbound specifically.

For a deeper dive on Zepbound across all FEHB plans, see our Does FEHB Cover Zepbound? 2026 Plan-by-Plan Guide.

Which FEP Blue plan is cheapest for GLP-1s in 2026?

Don't pick an FEP plan based on a blanket assumption. FEP's 2026 Abbreviated Formulary lists Wegovy as Tier 3 for Standard/Basic and NC for Focus, while FEP's GLP-1 exception FAQ says the correct tier is Tier 2 and that Focus Wegovy lands at Tier 2 only after an approved formulary exception. The only safe plan-comparison move is to run your full household drug list through MyBlue's Personalized Drug Cost Tool before Open Season.

1. FEP's own tier data is being corrected

FEP's 2026 Abbreviated Formulary shows Wegovy at Tier 3 anti-obesity for Standard and Basic and NC for Focus. FEP's pharmacy FAQ separately states the correct Wegovy tier is Tier 2 and that displayed tier data is being updated. Until those sources fully align, the only definitive answer for your plan and your cost-share is what shows up in the Personalized Drug Cost Tool when you log into MyBlue.

2. Focus is a closed formulary — it doesn't just affect GLP-1s

FEP Blue Focus has a closed formulary. Drugs that aren't on the Focus list aren't covered at all unless you successfully run a non-formulary exception. If anyone in your household takes other prescriptions — for blood pressure, mental health, asthma, a thyroid condition, or anything else — Focus could quietly cost you hundreds of dollars per month elsewhere to save on Zepbound. Run your full prescription list through the Drug Cost Tool before treating Focus as the obvious answer.

3. The "no tier exception" rule applies to GLP-1s

Once your prior approval or formulary exception is granted, you can't request to be moved to a lower tier for GLP-1s. The tier you land on is the tier you pay.

Bottom-line guidance:

  • Wegovy user, healthy otherwise: Compare premiums and other benefits between Standard, Basic, and Focus using the Drug Cost Tool with Wegovy specifically.
  • Zepbound user, healthy otherwise: If you have no other family medications, Focus may be cheaper for Zepbound after exception, but verify both your Zepbound exception odds and your household drug coverage first.
  • Multiple family members on multiple medications: Standard usually wins on overall household cost.
  • Open Season 2027 planning: Use the Personalized Drug Cost Tool on MyBlue to compare your specific situation.

Open Season for plan year 2026 has already ended, so this analysis is for planning your 2027 enrollment (typically opens mid-November 2026).

Postal workers (PSHB) — what's different?

Postal Service Health Benefits (PSHB) BCBS plans use the FEP Blue formulary, tier structure, prior approval criteria, and formulary exception process. Your GLP-1 coverage works under the same FEP-administered rules. Whether a specific telehealth provider's insurance concierge supports PSHB is a provider-by-provider question — confirm with each provider's intake before paying.

The Postal Service Health Benefits program launched January 1, 2025, replacing FEHB for postal employees and retirees. For PSHB members enrolled in BCBS Service Benefit Plan PSHB versions (Standard, Basic, Focus):

  • Same three plan options as FEHB
  • Same formulary tiers
  • Same prior approval criteria
  • Same comprehensive weight management program requirement
  • Same phone line for prior approval support: 1-877-727-3784

When a provider's intake form asks "do you have FEHB?", postal workers should enter their exact PSHB plan and member information, and ask the intake team whether their FEHB insurance-concierge support also covers PSHB. Don't assume yes — verify with the specific provider you're paying.

Federal retirees on FEP + Medicare (MPDP) — special rules

FEP annuitants in the FEP Medicare Prescription Drug Program (MPDP) get the same FEP health plan benefits, access to more approved prescription drugs than the traditional FEP prescription drug benefit, lower out-of-pocket costs for higher-cost drugs, and a $2,100 annual prescription drug cap in 2026. MPDP uses a different formulary exception form (phone: 1-855-344-0930) and is not available for FEP Blue Focus members.

The separate Medicare GLP-1 Bridge demonstration program starting July 2026 is not the same as your MPDP coverage.

What MPDP gives you

Per FEP's MPDP page (fepblue.org/medicarerx), MPDP members get:

  • Same FEP health plan benefits as before
  • More approved prescription drugs than the traditional FEP pharmacy benefit
  • Lower out-of-pocket costs for higher-cost drugs
  • A $2,100 annual prescription drug cap in 2026
  • Different formulary exception phone line: 1-855-344-0930

MPDP is not available for FEHB FEP Blue Focus members.

Before assuming any specific GLP-1 is covered under your MPDP plan, log into MyBlue and use the Personalized Drug Cost Tool — MPDP's drug list and cost-share are different from the Traditional FEHB pharmacy benefit.

The Medicare GLP-1 Bridge — separate from MPDP

Starting July 1, 2026 (it has not launched yet as of this page's verification date), CMS will run a separate Medicare GLP-1 Bridge demonstration through December 31, 2027, outside the standard Medicare Part D payment flow, with a $50 copay for eligible beneficiaries.

CMS Bridge eligibility criteria (narrower than press coverage usually suggests):

  • BMI ≥35, or
  • BMI ≥30 with HFpEF (heart failure with preserved ejection fraction), uncontrolled hypertension, or chronic kidney disease stage 3a or higher, or
  • BMI ≥27 with prediabetes, previous myocardial infarction, previous stroke, or symptomatic peripheral artery disease

Eligible Bridge products:

  • Foundayo (all formulations)
  • Wegovy (injection and tablets)
  • Zepbound KwikPen only

Not eligible: Zepbound single-dose vial; Zepbound single-dose pen.

For an FEP annuitant in MPDP, the Bridge program is a separate option that may or may not interact with MPDP in ways CMS will clarify closer to launch. Confirm directly with FEP Customer Care before electing one path over the other. For most FEP annuitants in 2026: keep your MPDP coverage, watch the Bridge program for 2027 planning purposes, and re-evaluate at Open Season.

What to do if your FEP Blue prior approval or exception is denied

Read the denial letter carefully — it must include the specific reason, your appeal rights, and the deadline (usually 180 days). Most denials are about missing documentation, not true exclusions. Fix the gap, resubmit through the correct route (standard PA, formulary exception, or non-formulary exception). If the appeal still fails, FDA-approved manufacturer-direct pricing through Ro, Sesame, LillyDirect, or NovoCare has dropped significantly in 2026.

The denial reason table

FEP Blue GLP-1 PA denial reasons and resubmission routes
Denial reasonWhat it usually meansExact resubmission route
BMI documentation missing or below thresholdYour file doesn't clearly show BMI ≥30 or BMI ≥27 with comorbidityHave your clinician document BMI on a recent visit; if comorbidity-pathway, make sure the diagnosis is coded (ICD-10) on a recent medical visit; resubmit standard PA
No comprehensive weight management program documentedFEP requires participation in a structured programEnroll in FEP Teladoc Weight Management, Noom, WeightWatchers, or an obesity-medicine clinic's structured program; document 3+ months before resubmitting
Dual PA weight-loss medication therapyYou are already on phentermine, Qsymia, Contrave, etc.Discontinue the conflicting medication, document the discontinuation, resubmit standard PA
Renewal denied — under 5% weight lossYou didn't hit FEP's renewal thresholdAsk whether maintenance of initial 5% loss qualifies; document your highest weight and current weight; resubmit renewal
Zepbound denied — preferred-product or two-oral-medication criteria not metFEP's Zepbound criteria weren't fully documentedDocument trial, intolerance, or contraindication to at least two oral weight-management medications AND trial of Wegovy or Saxenda (or valid medical reason those don't apply); resubmit as formulary exception
Drug excluded / Managed Not Covered on your planStandard PA was used when a formulary exception is neededSwitch routes — your clinician submits a formulary exception, not a standard PA
Not on FEP Blue Focus formulary at allNon-formulary exception is needed, not standard PASwitch routes — your clinician submits a non-formulary exception request

Your appeal rights

By federal regulation, your denial letter must include:

  • The specific reason for denial
  • Your appeal rights
  • The deadline to file (typically 180 days for FEHB plans — verify in your letter)

You can file the appeal yourself or your provider can. Document every phone call, save every fax confirmation.

FDA-approved cash-pay backup paths (if the appeal still fails)

Use this only after you've exhausted the FEP route.

  • LillyDirect: Zepbound vial $349/month; Zepbound KwikPen $449/month (7.5mg+)
  • NovoCare: Wegovy injection $499/month
  • Ro Body membership: Same FDA-approved pricing as LillyDirect and NovoCare, with Ro's care platform and 24/7 messaging
  • Sesame Care: Sesame's branded menu and per-visit pricing — but note the federal-program exclusion on Sesame's Wegovy/Ozempic promotional offer

An important FDA note: The FDA warns that illegally marketed semaglutide and tirzepatide products sold online may be counterfeit and may contain the wrong, harmful, too little, too much, or no active ingredient. FEP Blue does not cover compounded GLP-1 medications. Use state-licensed pharmacies only. (Source: FDA's Concerns with Unapproved GLP-1 Drugs.)

After a denial: see FDA-approved cash-pay options through Ro

Zepbound from $349/month and Wegovy from $499/month through Ro's self-pay option. Exhaust your FEP appeal first.

See Ro Cash-Pay Pricing → (sponsored affiliate link, opens in a new tab)

FEP Blue GLP-1 Path Finder

Answer 4 questions. Get your likely FEP route, exception requirements, and a documentation checklist tailored to your scenario.

1Which FEP Blue plan do you have?

2Which medication is your clinician considering?

3What is your BMI range?

4Do you have a qualifying condition?

What FEP Blue members actually said

We don't use testimonials to support medical claims, and we don't invent quotes. Here are two real, attributed voices that capture the friction this page is meant to fix.

From a federal employee forum thread (r/FedEmployees, posted January 2026):

"Doctor told me he had to submit prior authorization for Wegovy. Zepbound isn't covered. Which one do I even ask for when I don't know what the prices will be ahead of time?"

This is user-friction language — not coverage evidence. We include it because it is exactly the question this page is built to answer. (Source: Reddit r/FedEmployees thread.)

From a Ro patient (Ro members are paid for testimonials, per Ro's own disclosure):

"Ro has been invaluable. Initially, my insurance company covered Wegovy, and I was able to get a prescription and a prior authorization. During the Wegovy shortages, we waited — and waited — for it to come back in stock. While I was waiting, I saw that Ro had started offering Zepbound and contacted my doctor. They immediately switched my prescription to Zepbound."

Provider-experience testimonial — not medical-results or specific-price evidence. Individual experiences vary. Ro's insurance concierge cannot guarantee any specific coverage outcome. (Source: Ro 2025 GLP-1 Insurance Coverage Checker Report.)

What to ask before paying any GLP-1 provider with FEP Blue

The right question is not "do you accept FEP Blue?" The right questions are whether the provider's fee is cash-pay or billed to insurance, whether the medication will run through your FEP pharmacy benefit, who submits prior approval or formulary exception paperwork, and what happens if FEP denies coverage.

Copy and paste this script when you talk to any provider's intake team:

"I have FEP Blue [Standard / Basic / Focus / MPDP]. Before I pay anything, please confirm: (1) Is your membership or visit fee billed to FEP Blue or cash-pay? (2) If a GLP-1 is clinically appropriate for me, will the prescription run through my FEP pharmacy benefit? (3) Will your team submit standard prior approval, a formulary exception, or a non-formulary exception — depending on which my plan and drug require? (4) If FEP denies coverage, what cash-pay options do you offer, and can I cancel before ongoing membership charges?"

If you don't get clear answers, don't pay.

Safety and compliance basics

Insurance approval is not the same as medical appropriateness. A licensed clinician needs to evaluate your diagnosis, side effect risks, medication history, contraindications, and whether the request fits FEP's criteria. GLP-1 medications have important warnings — including possible serious side effects — that should be reviewed with a clinician before starting.

FDA-approved vs. compounded

  • FDA-approved branded GLP-1s for weight management: Wegovy (semaglutide injection), Wegovy pill (oral semaglutide for obesity), Zepbound (tirzepatide), Saxenda (liraglutide), and Foundayo (orforglipron, FDA-approved April 1, 2026).
  • FDA-approved branded GLP-1s for type 2 diabetes only: Ozempic, Mounjaro, Rybelsus. These may be prescribed off-label for weight loss in some clinical situations, but they are not FDA-approved for weight loss.
  • Compounded semaglutide and tirzepatide: Not FDA-approved finished drug products. The FDA has stated that compounded drugs have not been tested for safety, effectiveness, or quality in the same way as commercially manufactured medications. FEP Blue does not cover compounded GLP-1 medications.

No dual GLP-1 therapy

FEP policy prohibits dual therapy with another GLP-1 receptor agonist, and no dual therapy with another PA-required weight-loss medication. If you're already on phentermine, Qsymia, Contrave, Saxenda, or another GLP-1, you'll need to discontinue before starting a new one.

Online pharmacy caution

The FDA warns that illegally marketed semaglutide and tirzepatide products may be counterfeit and may contain the wrong, harmful, too little, too much, or no active ingredient. Use state-licensed pharmacies only.

Our methodology and what we actually verified

The RX Index is an independent comparison resource for GLP-1 telehealth providers. This page was built from FEP's own published formulary and pharmacy FAQ, from FEP's separate Wegovy and Zepbound criteria, from provider insurance and pricing pages, from OPM FEHB guidance, from CMS Medicare GLP-1 Bridge documentation, and from FDA safety statements. We earn affiliate commissions from some providers mentioned (disclosed inline), but coverage facts and FDA notes are never adjusted for compensation.

Source verification table

Source verification table for FEP Blue GLP-1 coverage claims
Claim typeSourceVerified date
FEP 2026 formulary tier placements for Wegovy, Saxenda, ZepboundFEP 2026 Abbreviated Formulary Book (fepblue.org PDF)May 12, 2026
FEP post-exception tier placements for Wegovy and ZepboundFEP pharmacy FAQ (fepblue.org/faqs/faq-pharmacy)May 12, 2026
Class-level weight-loss medication policy frameworkFEP Medical Policy 5.99.027 (fepblue.org PDF)May 12, 2026
Zepbound-specific PA criteria (two-oral-medication requirement, preferred-product trial)FEP Zepbound criteria document (Caremark FEP Criteria, Dec 2025)May 12, 2026
OPM anti-obesity coverage mandate for FEHB carriersOPM 2023 guidance; FedSmith analysisMay 12, 2026
FEP MPDP benefits, $2,100 annual cap, formulary exception phone linefepblue.org/medicarerxMay 12, 2026
Medicare GLP-1 Bridge launch date, eligibility criteria, and eligible productsCMS Medicare GLP-1 Bridge page (cms.gov)May 12, 2026
Ro FEHB carve-out language and insurance conciergero.co/weight-loss/ and ro.co/weight-loss/insurance/May 12, 2026
Sesame Care program structure and federal-program promo exclusionsesamecare.com/service/online-weight-loss-programMay 12, 2026
FEP Teladoc Weight Management Program eligibilityfepblue.org/manage-your-health/managing-specific-conditions/weightMay 12, 2026
FDA safety statements on unapproved GLP-1sfda.gov GLP-1 drug alertsMay 12, 2026

What you still need to verify yourself before relying on this for your prescription

  • Your exact FEP plan option (Standard / Basic / Focus / MPDP) — log into MyBlue at fepblue.org
  • Your specific drug cost using the FEP Personalized Drug Cost Tool
  • Whether your clinician's office submits ePA and formulary exceptions through CVS Caremark's FEP process
  • Whether your preferred pharmacy is in FEP's preferred network — Basic and Focus members can't use non-preferred retail pharmacies
  • Whether your specific provider's intake supports PSHB (if you are a postal worker)

Frequently asked questions

Does FEP Blue cover Wegovy in 2026?

FEP Blue has a real Wegovy path in 2026, but the tier answer depends on which FEP source you look at. The 2026 Abbreviated Formulary lists Wegovy as Tier 3 anti-obesity for Standard and Basic and NC for Focus. FEP's pharmacy FAQ separately says the correct Wegovy tier is Tier 2 across all three plans and that displayed tier data is being updated. Verify your actual cost-share in MyBlue's Personalized Drug Cost Tool before relying on a specific tier.

Does FEP Blue cover Zepbound in 2026?

Zepbound on FEP Blue is exception-driven. FEP's 2026 Abbreviated Formulary lists Zepbound as excluded on Standard and Managed Not Covered on Basic, and Zepbound is not on the Focus formulary. After an approved formulary exception, FEP's FAQ places Zepbound at Tier 3 non-preferred on Standard and Basic and Tier 2 Preferred on Focus. Your clinician must document FEP's full Zepbound criteria, including trial, intolerance, or contraindication to at least two oral weight-management medications, and trial of FEP's preferred product unless there is a valid medical exception.

Which FEP Blue plan is best for GLP-1 coverage?

Don't pick a plan based on a single drug. FEP's published formulary and FAQ disagree on Wegovy's tier, Zepbound is exception-driven on every plan, and FEP Blue Focus is a closed formulary that may not cover your other household medications. Run your full prescription list through MyBlue's Personalized Drug Cost Tool before Open Season.

Does Ro accept FEP Blue?

Ro Body membership is cash-pay and not billed to FEP, but Ro's insurance concierge explicitly extends to FEHB members to check coverage and submit prior approval. Ro currently lists Wegovy pen, Zepbound pen, and Ozempic as eligible GLP-1s through insurance. Once approved, the medication is filled at the in-network FEP pharmacy at the tier cost-share.

What documents are needed for FEP Blue prior approval for Wegovy or Zepbound?

You need: current BMI from a recent clinical measurement, a qualifying condition diagnosis if your BMI is 27–29.9, documentation of comprehensive weight management program participation, confirmation that you are not on another prior-authorization weight-loss medication, and your clinician's medical rationale. For Zepbound, you also need documented trial, intolerance, or contraindication to at least two oral weight-management medications, and trial of FEP's preferred product unless there is a valid medical reason. For renewal at month 6, documented 5% weight loss from baseline or maintenance of an initial 5% loss.

Are postal workers (PSHB) covered the same way for GLP-1s?

Yes. PSHB BCBS plans use the FEP Blue formulary, tier structure, prior approval criteria, and exception process. Whether a specific telehealth provider's insurance concierge supports PSHB is a provider-by-provider question — confirm with each provider's intake before paying.

Do FEP retirees on Medicare lose their weight-loss GLP-1 benefit?

FEP annuitants in the FEP Medicare Prescription Drug Program (MPDP) get the same FEP health plan benefits, access to more approved prescription drugs than the traditional FEP pharmacy benefit, lower out-of-pocket costs for higher-cost drugs, and a $2,100 annual prescription drug cap in 2026. MPDP uses a different formulary exception phone line and is not available for FEP Blue Focus members. Verify your specific drug's coverage in MyBlue before assuming.

Is the Medicare GLP-1 Bridge program the same as my MPDP?

No. The Medicare GLP-1 Bridge is a separate CMS demonstration program running July 1, 2026 through December 31, 2027, outside the standard Medicare Part D payment flow. Bridge eligibility criteria are narrower than press coverage usually suggests, and only specific products — Foundayo, all Wegovy formulations, and Zepbound KwikPen — are eligible. Zepbound vial and single-dose pen are not.

Is FEP Blue Focus a closed formulary?

Yes. FEP Blue Focus has a limited (closed) formulary, meaning drugs not on the Focus formulary are generally not covered without a successful non-formulary exception. Both Wegovy and Zepbound require an exception process on Focus.

Can I get Ozempic or Mounjaro through FEP Blue for weight loss?

Ozempic and Mounjaro are FDA-approved for type 2 diabetes, not weight loss. FEP Blue covers them for diabetes with prior approval. Some clinicians prescribe them off-label for weight loss, but FEP coverage for an off-label weight-loss prescription is generally harder to obtain than coverage for Wegovy or Zepbound for weight loss.

What if FEP Blue approves my request but the cost-share is still too high?

FEP Blue does not allow tier exceptions for GLP-1s — once approved, you pay the assigned tier cost-share. First, verify you are using a preferred retail pharmacy or the FEP Mail Service Program. Second, check the FEP Drug Cost Tool for your specific dose and pharmacy. Third, compare the cash-pay FDA-approved price through Ro, Sesame, LillyDirect, or NovoCare — in 2026, manufacturer-direct pricing has dropped to $349–$499 per month for some Zepbound and Wegovy doses, which may beat your tier cost-share.

Will FEP Blue cover compounded semaglutide or tirzepatide?

No. FEP Blue only covers FDA-approved GLP-1 medications. Compounded versions are not FDA-approved finished drug products and are not part of the FEP pharmacy benefit.

Still not sure which GLP-1 path is right for you?

Federal employees have legitimate weight-loss GLP-1 coverage in 2026. The path is real — it just takes the right provider and the right paperwork. Take our free 60-second matching quiz.

Get your personalized GLP-1 action plan →

60 seconds. No signup. Free.

The RX Index is an independent comparison resource for GLP-1 telehealth providers. This page is not medical advice. We are not affiliated with Blue Cross Blue Shield, the BCBSA, the Office of Personnel Management, or any FEHB carrier. Last verified: May 12, 2026. Next audit: August 12, 2026. Some links on this page are sponsored affiliate links — see our affiliate disclosure.